May 8, 2024, 02:11
Piet Ost: RADIOSA trial at ESTRO24
Piet Ost, Assistant Professor of Radiation Oncology at Ghent University, shared on X/Twitter:
“RADIOSA trial:
- oligorecurrent PCa SBRT vs SBRT + 6 months ADT
- ADT improved bRFS and cRFS
- more polymetastatic recurrences in the ADT arm.
- would love to see eugonad-relapse free survival.
- will be interesting to see QoL data and compare with the DART trial.
ESTRO24.”
Source: Piet Ost/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 18, 2024, 00:08
Sep 17, 2024, 22:04
Sep 17, 2024, 22:00
Sep 17, 2024, 21:57
Sep 17, 2024, 21:53
Sep 17, 2024, 21:50
Sep 17, 2024, 19:54
Sep 17, 2024, 19:48
Sep 17, 2024, 19:39